BRIEF-Medicinova announces interim data from clinical trial of MN-166 (ibudilast) in ALS

* Announces interim data from clinical trial of MN-166

(ibudilast) in ALS presented at the American Academy of

Neurology (AAN) 68th annual meeting in Vancouver, Canada

Read more